Your session is about to expire
← Back to Search
Arm A: Provider Educational Intervention for Alzheimer's Disease (ORCHID Trial)
N/A
Waitlist Available
Led By Magdalena I Tolea, PhD
Research Sponsored by Florida Atlantic University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months, and 12 months post-intervention
Awards & highlights
ORCHID Trial Summary
This trial tests a protocol to help rural communities diagnose and treat Alzheimer's and dementia better.
Eligible Conditions
- Alzheimer's Disease
ORCHID Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 months, 6 months, and 12 months post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months, and 12 months post-intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in AD knowledge
Change in AD literacy treatment plan.
Change in rates of new dementia diagnosis and treatment
+1 moreSecondary outcome measures
Change in caregiver burden
Change in caregiver self-efficacy
Change in provider confidence in establishing an ADRD diagnosis and treatment plan
+2 moreORCHID Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm A: Provider Educational InterventionExperimental Treatment1 Intervention
Providers receiving education/support from neurology teams, Adult Gerontological Nurse Practitioner (AGNP) assessments/recommendations, and training of office staff regarding ADRD and community resources support for patients/caregivers.
Group II: Arm B: Provider ControlActive Control1 Intervention
Providers receiving AGNP assessments/recommendations only.
Find a Location
Who is running the clinical trial?
Florida Atlantic UniversityLead Sponsor
30 Previous Clinical Trials
9,513 Total Patients Enrolled
University of MiamiOTHER
912 Previous Clinical Trials
411,137 Total Patients Enrolled
Palm Beach State CollegeUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are committed to residing in the Glades Area for at least the next year.You have no established diagnosis of Alzheimer's Disease and Related Dementias.You are able to communicate in English, Spanish, or Creole.You are at least 50 years of age.You have been diagnosed with a disease related to dementia in the past.You are younger than 50 years old.You reside in the Glades region of Florida.You are a resident of the local area and not living in an institutional facility.
Research Study Groups:
This trial has the following groups:- Group 1: Arm A: Provider Educational Intervention
- Group 2: Arm B: Provider Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger